Royal Bank of Canada’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-698
| Closed | -$38K | – | 8267 |
|
|
2022
Q2 | $38K | Sell |
698
-917
| -57% | -$48.1K | ﹤0.01% | 5845 |
|
|
2022
Q1 | $52K | Sell |
1,615
-1,125
| -41% | -$32.3K | ﹤0.01% | 6071 |
|
|
2021
Q4 | $59K | Buy |
2,740
+612
| +29% | +$13.5K | ﹤0.01% | 6284 |
|
|
2021
Q3 | $47K | Hold |
2,128
| – | – | ﹤0.01% | 6213 |
|
|
2021
Q2 | $41K | Hold |
2,128
| – | – | ﹤0.01% | 6177 |
|
|
2021
Q1 | $37K | Hold |
2,128
| – | – | ﹤0.01% | 6078 |
|
|
2020
Q4 | $34K | Hold |
2,128
| – | – | ﹤0.01% | 5828 |
|
|
2020
Q3 | $23K | Sell |
2,128
-17,456
| -89% | -$208K | ﹤0.01% | 5651 |
|
|
2020
Q2 | $237K | Sell |
19,584
-4,382
| -18% | -$54.4K | ﹤0.01% | 4329 |
|
|
2020
Q1 | $235K | Buy |
23,966
+5,300
| +28% | +$69.4K | ﹤0.01% | 4214 |
|
|
2019
Q4 | $256K | Buy |
18,666
+18,588
| +23,831% | +$243K | ﹤0.01% | 4465 |
|
|
2019
Q3 | $1K | Buy |
78
+75
| +2,500% | +$1.44K | ﹤0.01% | 6578 |
|
|
2019
Q2 | $0 | Sell |
3
-25
| -89% | -$1.21K | ﹤0.01% | 7333 |
|
|
2019
Q1 | $2K | Hold |
28
| – | – | ﹤0.01% | 6576 |
|
|
2018
Q4 | $1K | Hold |
28
| – | – | ﹤0.01% | 6639 |
|
|
2018
Q3 | $2K | Hold |
28
| – | – | ﹤0.01% | 6549 |
|
|
2018
Q2 | $3K | Hold |
28
| – | – | ﹤0.01% | 6205 |
|
|
2018
Q1 | $2K | Hold |
28
| – | – | ﹤0.01% | 6147 |
|
|
2017
Q4 | $4K | Sell |
28
-6
| -18% | -$577 | ﹤0.01% | 6156 |
|
|
2017
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 6580 |
|
|
2017
Q2 | $1K | Hold |
34
| – | – | ﹤0.01% | 6466 |
|
|
2017
Q1 | $2K | Hold |
34
| – | – | ﹤0.01% | 6455 |
|
|
2016
Q4 | $2K | Hold |
34
| – | – | ﹤0.01% | 6501 |
|
|
2016
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 6216 |
|
|
2016
Q2 | $2K | Buy |
+34
| New | +$6.48K | ﹤0.01% | 6177 |
|
Other funds holding SRRA
Royal Bank of Canada's SRRA Position: Q3 2022 in Review
Royal Bank of Canada sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 698 shares — an estimated $38K sold.
Royal Bank of Canada first reported a position in SRRA in Q2 2016 and held it in 25 quarters. The position peaked at $256K in Q4 2019. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- Royal Bank of Canada reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Royal Bank of Canada sold 698 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $38K.
- Royal Bank of Canada first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2016 and held it in 25 quarters.
- Royal Bank of Canada's Sierra Oncology, Inc. Common Stock position peaked at $256K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.